SEC FORM 4
$2,149,676.49
Caris Life Sciences, Inc. (CAI)
Sale of 84,900 shares at $25.3201 per share.
Reporting Person Spetzler David Baxley · Officer Title President · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0002071953-26-000007 · filed 2026-09-04 · View filing →